Minerva Neurosciences Reports Third Quarter 2022 Financial Results and Business Updates

Go back to Minerva Neurosciences Reports Third Quarter 2022 Financial Results and Business Updates

Minerva Neurosciences (NERV) Tops Q3 EPS by 9c

November 9, 2022 8:17 AM EST

Minerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of ($1.29), $0.09 better than the analyst estimate of ($1.38).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

... More